Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Biotronik heart disease study validated by medical journal

Biotronik heart disease study validated by medical journal

13th October 2010

Biotronik has received a validation for its planned study into the benefits of cardiac resynchronisation therapy (CRT) by a leading medical publication.

The September 23rd 2010 issue of the European Heart Journal has included a peer-reviewed article which outlines and endorses the rationale behind the forthcoming Biotronik-sponsored EchoCRT trial.

This study will take place across 125 international sites and will use echocardiography to assess the impact of CRT among patients with conditions such as advanced heart failure, narrow QRS complex and documented mechanical dyssynchrony.

According to the European Heart Journal paper, the benefits of CRT will remain unclear until the final results from the study are published.

Marlou Janssen, global vice-president of marketing and sales at Biotronik, said: "We believe that clinical excellence is achieved by conducting studies of major significance where outcomes will provide answers to the most important clinical questions regarding the unmet needs of patients and physicians."

Earlier this month, the medical technology firm published data from a study showing the benefits of gold-tip catheters among patients suffering from atrial flutter.ADNFCR-8000103-ID-800113950-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.